Trending NewsTrending NewsLowest-Rated StocksLowest-RatedMost-Downgraded StocksMost-DowngradedNASDAQ:VRNA Verona Pharma PLC American Depositary Share (VRNA) Stock Price, News & Analysis $105.40 +0.01 (+0.01%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$104.90 -0.50 (-0.47%) As of 08/7/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Verona Pharma PLC American Depositary Share Stock (NASDAQ:VRNA) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get VRNA alerts:Sign Up Key Stats Today's Range$105.19▼$105.4050-Day Range$80.83▼$105.4752-Week Range$19.75▼$105.50Volume1.86 million shsAverage Volume5.00 million shsMarket Capitalization$8.97 billionP/E RatioN/ADividend YieldN/APrice Target$109.00Consensus RatingHold Company Overview Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom. Read More Verona Pharma PLC American Depositary Share Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks38th Percentile Overall ScoreVRNA MarketRank™: Verona Pharma PLC American Depositary Share scored higher than 38% of companies evaluated by MarketBeat, and ranked 745th out of 921 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.1 / 5Analyst RatingHold Consensus RatingVerona Pharma PLC American Depositary Share has received a consensus rating of Hold. The company's average rating score is 2.15, and is based on 2 buy ratings, 11 hold ratings, and no sell ratings.Amount of Analyst CoverageVerona Pharma PLC American Depositary Share has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Verona Pharma PLC American Depositary Share's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Verona Pharma PLC American Depositary Share are expected to grow in the coming year, from ($1.95) to $0.03 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Verona Pharma PLC American Depositary Share is -106.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Verona Pharma PLC American Depositary Share is -106.46, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioVerona Pharma PLC American Depositary Share has a P/B Ratio of 41.17. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Verona Pharma PLC American Depositary Share's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted4.77% of the outstanding shares of Verona Pharma PLC American Depositary Share have been sold short.Short Interest Ratio / Days to CoverVerona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Verona Pharma PLC American Depositary Share has recently increased by 6,533.99%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldVerona Pharma PLC American Depositary Share does not currently pay a dividend.Dividend GrowthVerona Pharma PLC American Depositary Share does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted4.77% of the outstanding shares of Verona Pharma PLC American Depositary Share have been sold short.Short Interest Ratio / Days to CoverVerona Pharma PLC American Depositary Share has a short interest ratio ("days to cover") of 1.2, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Verona Pharma PLC American Depositary Share has recently increased by 6,533.99%, indicating that investor sentiment is decreasing significantly. News and Social Media3.1 / 5News Sentiment0.51 News SentimentVerona Pharma PLC American Depositary Share has a news sentiment score of 0.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 34 news articles for Verona Pharma PLC American Depositary Share this week, compared to 9 articles on an average week.Search Interest9 people have searched for VRNA on MarketBeat in the last 30 days. This is an increase of 80% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added Verona Pharma PLC American Depositary Share to their MarketBeat watchlist in the last 30 days. This is a decrease of -43% compared to the previous 30 days. Company Ownership2.5 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Verona Pharma PLC American Depositary Share insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $24,613,268.00 in company stock.Percentage Held by InsidersOnly 4.80% of the stock of Verona Pharma PLC American Depositary Share is held by insiders.Percentage Held by Institutions85.88% of the stock of Verona Pharma PLC American Depositary Share is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Verona Pharma PLC American Depositary Share's insider trading history. Receive VRNA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Verona Pharma PLC American Depositary Share and its competitors with MarketBeat's FREE daily newsletter. Email Address VRNA Stock News HeadlinesJames Aloysius Brady Sells 824 Shares of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) StockAugust 6 at 6:34 AM | insidertrades.comVerona Pharma PLC American Depositary Share (NASDAQ:VRNA) Sees Significant Growth in Short InterestAugust 3, 2025 | americanbankingnews.comIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd. | Brownstone Research (Ad)Brokerages Set Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) Target Price at $109.00August 2, 2025 | americanbankingnews.comMerck’s $10B Verona Deal: A High-Stakes Play in Respiratory CareJuly 29, 2025 | msn.comHC Wainwright & Co. Downgrades Verona Pharma plc - Depositary Receipt () (VRNA)July 15, 2025 | msn.comWhat Makes Verona Pharma PLC American Depositary Share (VRNA) a Strong Momentum Stock: Buy Now?July 15, 2025 | msn.com$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Verona Pharma plc (NASDAQ: VRNA)July 14, 2025 | globenewswire.comSee More Headlines VRNA Stock Analysis - Frequently Asked Questions How have VRNA shares performed this year? Verona Pharma PLC American Depositary Share's stock was trading at $46.44 on January 1st, 2025. Since then, VRNA stock has increased by 127.0% and is now trading at $105.40. How were Verona Pharma PLC American Depositary Share's earnings last quarter? Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) issued its quarterly earnings data on Wednesday, August, 6th. The company reported $0.13 EPS for the quarter, beating the consensus estimate of ($0.01) by $0.14. The firm had revenue of $103.14 million for the quarter, compared to the consensus estimate of $90.41 million. Verona Pharma PLC American Depositary Share had a negative net margin of 36.62% and a negative trailing twelve-month return on equity of 23.69%. When did Verona Pharma PLC American Depositary Share IPO? Verona Pharma PLC American Depositary Share (VRNA) raised $61 million in an initial public offering on Thursday, April 27th 2017. The company issued 4,500,000 shares at a price of $13.49 per share. Jefferies and Stifel served as the underwriters for the IPO and Wedbush PacGrow and SunTrust Robinson Humphrey were co-managers. Who are Verona Pharma PLC American Depositary Share's major shareholders? Top institutional shareholders of Verona Pharma PLC American Depositary Share include Jennison Associates LLC (1.03%), Allspring Global Investments Holdings LLC (0.62%), TD Asset Management Inc (0.26%) and Bank of New York Mellon Corp (0.12%). Insiders that own company stock include David Zaccardelli, Mark W Hahn, Orbimed Advisors Llc, Kathleen A Rickard, Claire Poll, David R Ebsworth, Andrew Fisher, Martin Edwards, Vikas Sinha, Mahendra Shah, Lisa Deschamps, Kenneth Cunningham, James Aloysius Brady and Michael Austwick. View institutional ownership trends. How do I buy shares of Verona Pharma PLC American Depositary Share? Shares of VRNA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Verona Pharma PLC American Depositary Share own? Based on aggregate information from My MarketBeat watchlists, some other companies that Verona Pharma PLC American Depositary Share investors own include Cisco Systems (CSCO), Philip Morris International (PM), NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Home Depot (HD) and CrowdStrike (CRWD). Company Calendar Last Earnings8/06/2025Today8/08/2025Next Earnings (Estimated)8/14/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry MED - BIOMED/GENE Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:VRNA CIK1657312 Webwww.veronapharma.com Phone011-44-0-2032834200FaxN/AEmployees30Year FoundedN/APrice Target and Rating Average Price Target for Verona Pharma PLC American Depositary Share$109.00 High Price Target$170.00 Low Price Target$57.00 Potential Upside/Downside+3.4%Consensus RatingHold Rating Score (0-4)2.15 Research Coverage13 Analysts Profitability EPS (Trailing Twelve Months)($2.00) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$173.42 million Net Margins-36.62% Pretax Margin-130.46% Return on Equity-23.69% Return on Assets-9.63% Debt Debt-to-Equity Ratio1.07 Current Ratio8.86 Quick Ratio8.73 Sales & Book Value Annual Sales$42.28 million Price / Sales212.22 Cash FlowN/A Price / Cash FlowN/A Book Value$2.56 per share Price / Book41.17Miscellaneous Outstanding Shares85,130,000Free Float81,046,000Market Cap$8.97 billion OptionableOptionable Beta0.12 Social Links Beginner's Guide To Retirement StocksEnter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio. Get This Free Report This page (NASDAQ:VRNA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma PLC American Depositary Share Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma PLC American Depositary Share With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.